-- Bayer Is Asked for More Xarelto Data by U.K. Health-Cost Agency
-- B y   K r i s t e n   H a l l a m
-- 2012-03-13T00:01:00Z
-- http://www.bloomberg.com/news/2012-03-13/bayer-asked-for-xarelto-data-by-u-k-health-cost-agency.html
The U.K.â€™s health-cost agency asked
 Bayer AG (BAYN)  for more information on the cost and effectiveness of
the Xarelto blood-thinning drug in the treatment and prevention
of clots in deep veins.  The data presented by the German drugmaker failed to show
Xarelto offered value for money to the state-run  National Health
Service , the National Institute for Health and Clinical
Excellence said today in an e-mailed statement. Bayer, health-
care professionals and members of the public may now comment on
the draft guidance, the agency said.  To contact the reporter on this story:
Kristen Hallam in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  